صفحة الممارس الصحي

الحملات

View All

الوثائق

View All

2026-10-14

Regulatory guidance for submissions and applications

Drugs

More

Download

2026-09-29

Guideline on the Quality Requirements of Synthetic Peptides

Drugs

More

Download

2020-03-02

Guidance for Combination Products Classification

Food

Drugs

Medical Devices

Cosmetics

More

Download

2023-05-21

Health Practitioner's Acknowledgement and Pledge Form

Medical Devices

More

Download

2021-08-12

Disclosure and Undertaking Form for Requesting Permission to Import Distillation Devices

Drugs

Medical Devices

More

Download

2022-02-09

Attestation for Importers of Minimally Manipulated Biological Products Intended for Human Application Form

Drugs

Medical Devices

More

Download

المركز الإعلامي

View All

2026-10-28

SFDA Grants Breakthrough Designation of a Drug Targeting the Treatment of Certain Types of Cancer Under the Breakthrough Program

The Saudi Food and Drug Authority (SFDA) has announced its approval to designate a drug under the Breakthrough Medicines Program for the treatment of...

More

2026-10-19

SFDA Grants Breakthrough Designation to "Povetacicept" for Adults with Primary Immunoglobulin A Nephropathy

The Saudi Food and Drug Authority (SFDA) has granted Breakthrough Designation to “Povetacicept”, developed by Vertex Pharmaceuticals Inc., under the...

More

2026-10-07

SFDA and Saudi NIH Launch Five Initiatives to Advance Clinical Trials and Accelerate Innovative Medicines Development in Saudi Arabia

H.E. Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), launched a number of strategic initiatives in clinical trials in...

More

2026-10-07

SFDA Grants Breakthrough Designation to "Wilsirdli" for Early, Advanced, and Metastatic ER+/HER2- Breast Cancer

The Saudi Food and Drug Authority (SFDA) has approved a request by Roche Pharmaceuticals to designate "Wilsirdli" under its Breakthrough Medicine...

More

2026-10-06

SFDA CEO: Crown Prince’s Blood Donation Initiative Embodies Noble Values and Helps Save Lives

H.E. the CEO of the Saudi Food and Drug Authority (SFDA), Dr. Hisham S. Aljadhey, expressed his gratitude and appreciation to HRH Prince Mohammed bin...

More

2026-10-03

SFDA Approves Registration of "Jascayd" for the Treatment of Idiopathic Pulmonary Fibrosis

The Saudi Food and Drug Authority (SFDA) has approved the registration of Jascayd (nerandomilast) for the treatment of adult patients with idiopathic...

More